Influence of DNA ploidy and adjuvant treatment on progression and survival in patients with pathologic stage T3 (pT3) prostate cancer after radical retropubic prostatectomy

By Hawkins C.A.   Bergstralh E.J.   Lieber M.M.   Zincke H.  

Urology, Vol. 46, Iss. 3, 1995-09 ,pp. : 356-364

Elsevier

Access to resources Recommend Favorite

Second Transurethral Resection and Adjuvant Radiotherapy in Conservative Treatment of pT2N0M0 Bladder Tumors

By Geavlete P.   Georgescu D.   Florea I.  

European Urology, Vol. 43, Iss. 5, 2003-05 ,pp. : 499-504

Elsevier

Access to resources Recommend Favorite

Thrombospondin-1 expression in patients with pathologic stage T3 prostate cancer undergoing radical prostatectomy: association with p53 alterations, tumor angiogenesis, and tumor progression

By Grossfeld G.D.   Carroll P.R.   Lindeman N.   Meng M.   Groshen S.   Feng A.-C.   Hawes D.   Cote R.J.  

Urology, Vol. 59, Iss. 1, 2002-01 ,pp. : 97-102

Elsevier

Access to resources Recommend Favorite

Pathologic Determinants of Survival After Resection of T3N0 (Stage IIA) Colorectal Cancer: Proposal for a New Prognostic Model

By Cianchi Fabio   Messerini Luca   Comin Camilla   Boddi Vieri   Perna Federico   Perigli Giuliano   Cortesini Camillo  

Diseases of the Colon & Rectum, Vol. 50, Iss. 9, 2007-09 ,pp. : 1332-1341

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic factors in patients with resected pathologic (p-) T1-2N1M0 non-small cell lung cancer (NSCLC)

By Tanaka F.   Yanagihara K.   Otake Y.   Yamada T.   Shoji T.   Miyahara R.   Inui K.   Wada H.  

European Journal of Cardio-Thoracic Surgery, Vol. 19, Iss. 5, 2001-05 ,pp. : 555-561

Elsevier

Access to resources Recommend Favorite